A Case of Pathologic Nystagmus following Chemotherapy Using Carboplatin for Small Cell Lung Cancer: A Case Report.
- Author:
Ji Yong KIM
1
;
Jung Hyun PARK
;
Jin Hyong LEE
;
Hyoung Seop KIM
Author Information
- Publication Type:Case Report
- Keywords: carboplatin; ototoxicity; pathologic nystagmus
- MeSH: Activities of Daily Living; Brain; Carboplatin; Dizziness; Eye; Hearing; Humans; Lung; Male; Middle Aged; Neoplasm Metastasis; Nystagmus, Pathologic; Paraneoplastic Syndromes; Small Cell Lung Carcinoma
- From:Brain & Neurorehabilitation 2013;6(2):82-85
- CountryRepublic of Korea
- Language:English
- Abstract: A quadriparetic 62-year-old male patient completely cured from small cell lung cancer was admitted to the hospital. The patient complained of dizziness and spontaneous horizontal nystagmus was present in both eyes. He was tolerable during the cancer treatment, but 4 months later he became bed ridden status and totally dependent on all of the daily living activities. Brain metastasis of primary cancer and paraneoplastic syndrome were suspected first, however the brain MRI and paraneoplastic antibody study revealed negative result. With reviewing his medical history, he took chemotherapy including carboplatin. We suspected the ototoxicity induced by carboplatin, as carboplatin has a unique side effect including ototoxicity affecting the balance function while preserving the hearing function. Clinicians should keep in mind this adverse effect in any patient with chemotherapy including carboplatin and who subsequently develops nystagmus and functional level impairment. In such, we present this case with the related literatures.
